Literature DB >> 24293282

Challenges in measuring medication adherence: experiences from a controlled trial.

Kay Stewart1, Kevin P Mc Namara, Johnson George.   

Abstract

Measurement of adherence is complex and many methods, both direct and indirect are used; there is no universal gold standard. In this article, we share our experiences in a randomised controlled study, the Hypertension Adherence Program in Pharmacy trial, evaluating a community pharmacy-based intervention for improving adherence to antihypertensive medication. Several objective and subjective measures of adherence (Morisky score, TABS score, MedsIndex, Medicines Possession Ratio) were used, but produced varying results, limiting confidence in the conclusions that could be drawn. Despite using a specifically designed data mining software program to identify potentially nonadherent patients from dispensing records, many participants were found to be adherent by the self reported Morisky scale. A lesson to be learned when targeting people for interventions to improve adherence is that information from dispensing records should be supplemented by other methods in order to identify patients most in need of assistance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24293282     DOI: 10.1007/s11096-013-9877-6

Source DB:  PubMed          Journal:  Int J Clin Pharm


  17 in total

Review 1.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

Review 2.  Medication adherence and persistence as the cornerstone of effective antihypertensive therapy.

Authors:  Michel Burnier
Journal:  Am J Hypertens       Date:  2006-11       Impact factor: 2.689

3.  Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations.

Authors:  Thomas J Bramley; Philip P Gerbino; Brian S Nightengale; Feride Frech-Tamas
Journal:  J Manag Care Pharm       Date:  2006-04

Review 4.  The assessment of refill compliance using pharmacy records: methods, validity, and applications.

Authors:  J F Steiner; A V Prochazka
Journal:  J Clin Epidemiol       Date:  1997-01       Impact factor: 6.437

5.  Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle risk factor study 2004-2006.

Authors:  E D Janus; S J Bunker; A Kilkkinen; K Mc Namara; B Philpot; P Tideman; R Tirimacco; T K Laatikainen; S Heistaro; J A Dunbar
Journal:  Intern Med J       Date:  2008-02-14       Impact factor: 2.048

6.  Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial.

Authors:  Rosalind Lau; Kay Stewart; Kevin P McNamara; Shane L Jackson; Jeffery D Hughes; Gregory M Peterson; Diana A Bortoletto; Jenny McDowell; Michael J Bailey; Arthur Hsueh; Johnson George
Journal:  BMC Health Serv Res       Date:  2010-02-05       Impact factor: 2.655

7.  Persistence with antihypertensive medication: Australia-wide experience, 2004-2006.

Authors:  Leon A Simons; Michael Ortiz; Gordon Calcino
Journal:  Med J Aust       Date:  2008-02-18       Impact factor: 7.738

8.  Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab).

Authors:  Esther M Briganti; Jonathan E Shaw; Steven J Chadban; Paul Z Zimmet; Timothy A Welborn; John J McNeil; Robert C Atkins
Journal:  Med J Aust       Date:  2003-08-04       Impact factor: 7.738

Review 9.  Medication compliance and persistence: terminology and definitions.

Authors:  Joyce A Cramer; Anuja Roy; Anita Burrell; Carol J Fairchild; Mahesh J Fuldeore; Daniel A Ollendorf; Peter K Wong
Journal:  Value Health       Date:  2008 Jan-Feb       Impact factor: 5.725

10.  Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease.

Authors:  P Michael Ho; David J Magid; Frederick A Masoudi; David L McClure; John S Rumsfeld
Journal:  BMC Cardiovasc Disord       Date:  2006-12-15       Impact factor: 2.298

View more
  6 in total

1.  The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation.

Authors:  David J Taber; James N Fleming; Cory E Fominaya; Mulugeta Gebregziabher; Kelly J Hunt; Titte R Srinivas; Prabhakar K Baliga; John W McGillicuddy; Leonard E Egede
Journal:  Am J Nephrol       Date:  2016-12-02       Impact factor: 3.754

2.  Measuring medication adherence in patients with incident hypertension: a retrospective cohort study.

Authors:  Karen L Tang; Hude Quan; Doreen M Rabi
Journal:  BMC Health Serv Res       Date:  2017-02-13       Impact factor: 2.655

3.  Medication adherence in renal transplant recipients: A latent variable model of psychosocial and neurocognitive predictors.

Authors:  Theone S E Paterson; Norm O'Rourke; R Jean Shapiro; Wendy Loken Thornton
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

4.  Impact of Once- Versus Twice-Daily Tacrolimus Dosing on Medication Adherence in Stable Renal Transplant Recipients: A Canadian Single-Center Randomized Controlled Trial.

Authors:  Theone S E Paterson; Maryam Demian; Rebecca Jean Shapiro; Wendy Loken Thornton
Journal:  Can J Kidney Health Dis       Date:  2019-08-17

5.  Medication Adherence, Burden and Health-Related Quality of Life in Adults with Predialysis Chronic Kidney Disease: A Prospective Cohort Study.

Authors:  Wubshet H Tesfaye; Charlotte McKercher; Gregory M Peterson; Ronald L Castelino; Matthew Jose; Syed Tabish R Zaidi; Barbara C Wimmer
Journal:  Int J Environ Res Public Health       Date:  2020-01-06       Impact factor: 3.390

6.  Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial.

Authors:  Juan Carlos Montano-Pedroso; Elvio Bueno Garcia; Neil Ferreira Novo; Daniela Francescato Veiga; Lydia Masako Ferreira
Journal:  Trials       Date:  2016-04-12       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.